Clinical Trial Update: Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating radiation therapy with temozolomide for newly diagnosed glioblastoma or gliosarcoma has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Radiation therapy
• Temozolomide (Temozolomide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 3 | Status: COMPLETED | Results posted: 2014-04-30